The latest issue of MIT Technology Review, a bi-monthly magazine owned by the Massachusetts Institute of Technology, contains a piece by Michal “Mikki” Tal, formerly of Stanford University, discussing immune responses to cancer and Lyme disease, the latter of which looks a whole lot like so-called “Long COVID.”
The article
explains that after the Wuhan coronavirus (COVID-19) “pandemic” was
launched in early 2020, in-person research on cancer and Lyme disease
ceased, which drove Tal into looking at the salivary immune response to
COVID. She discovered that salivary immune response to COVID is
strikingly similar to that of Lyme.
“Long COVID looks exactly, and I mean exactly, like chronic
Lyme,” Tal noted. “One is caused by bacteria, and one is caused by a
virus. And I started to ask myself this question: Does it matter which
road you took to Rome? Or does it only matter that you’re in Rome?”
The crux of Tal’s longtime research into cancer and Lyme centered
around the way healthy cells in the body broadcast a message to the
immune system of “don’t eat me” while cancerous or infected cells tell
the immune system to “eat me.” In the process of probing all this, Tal
discovered something she described as “very odd:” the fact that the
receptor that receives the healthy cells’ signal of “don’t eat me”
varies tremendously from person to person.
Some believe that the diversity of these receptors is a product
of evolutionary biology while others believe that pathogens themselves
evolve to produce their own chemical mimics of the response, protecting
themselves from the immune system. As a result, the immune system
develops its own wide range of locks to outsmart the pathogens.
Lyme is one of those really smart bacterial infections that produces a
special protein capable of establishing a lasting infection. Known
scientifically as Borrelia burgdorferi, Lyme bacteria’s special
protein mimics the “don’t eat me” signal of healthy cells, effectively
prolonging its presence in the body.
As Tal continued her research, she learned that the effect of
this mimicking signal in patients who take antibiotic treatments for
Lyme is that around 10 percent of them go on to develop chronic symptoms
that are nearly identical to Long COVID: things like crushing pain,
debilitating fatigue and cognitive abnormalities.
Mystery bioweapons
As many Lyme patients now know, the medical establishment’s response
to these long-term symptoms is to basically deny them, instead calling
them a form of mental illness. In fact, there is still no objective way
to diagnose chronic Lyme, nor is there any medically established therapy
to treat it.
When COVID came along and Tal’s in-person Lyme research hit a
pause, she started studying COVID patients who never recovered from
their acute symptoms like many others. She observed the same array of
bewildering, long-term symptoms that occur in chronic Lyme patients.
It turns out that whatever COVID is, virus or otherwise, does the
very same thing as Lyme by producing stubbornly persistent pathogens
that continually outsmart the immune system’s ability to destroy them.
The end result is a seemingly never-ending illness with no established
cure.
Even so, Tal is convinced that one day there could be a remedy
for both Long COVID and Lyme, especially if they turn out to be one and
the same.
“I’m convinced this is a solvable problem,” she said. “I’ve
thrown everything I can at trying to find it. And I really hope that we
do.”
“It is high time that an army of people from all over the world
arrest and deal with all those involved in bioweapons production,” added
a commenter.
Click this link for the original source of this article.
Author: Planet Today
This content is courtesy of, and owned and copyrighted by, https://www.planet-today.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.